Indian companies maintained their dominance in the IPM with a share of 79 per cent and grew combined at a strong 11 per cent growth rate
THE INDIAN Pharmaceutical Market (IPM) clocked ₹ 120788 crores and grew at 6.3 per cent as of MAT February 2018 and was valued at ₹ 9992 crores for the month of February. The retail sector was valued at ₹ 102188 crores and showed a growth of 7.0 per cent. The growth for IPM was 10 per cent.
Top 10 companies showed a double digit growth of 11 per cent over SPLY and clocked a combined revenue of ₹ 4319 crores with their share slight decreasing and coming down to 43 per cent in the IPM. Rank 4-7 set of top 10 companies grew in double digits with Mankind (21 per cent), Alkem (16 per cent), Macleods (14 per cent) and Lupin (11 per cent) being amongst companies with strong growths. Companies in 11-20 bracket grew even better at 13 per cent combined where Aristo (19 per cent) and Glenmark (13 per cent) were among the fastest growing companies.
Top 10 brands in the IPM were valued at ₹ 322 crores combined and showed a growth of 9 per cent which was slightly lesser than the IPM. 7 of the top 10 brands showed double digit growth with Clavam (26 per cent) and Thyronorm (23 per cent) leading the way for the month of February 2018. Only Novomix (-21 per cent) showed de-growth among top 10 brands. Brands ranked 11- 20 grew strongly at 18 per cent combined growth where Panderm+ (56 per cent) and Monocef (36 per cent) were amongst the fastest growing. These brands were valued at ₹ 231 crore for the month.
この記事は Express Pharma の Express Pharma (Vol.13, No.11) April 1-15, 2018 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Express Pharma の Express Pharma (Vol.13, No.11) April 1-15, 2018 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation